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 Asthma is a world wide chronic disease with an estimated 300 million affected 
individual. The medications for asthma therapy consist of several drugs, causing asthma patients 
susceptible to polypharmacy as a result of frequent use of multiple drugs simultaneously. This 
occur to appear a great concern of drug interactions as known to be related to adverse drug 
reactions and hospitalization, therefore a study to analyze the possibility of drug interactions in 
asthma patients is needed. This study consisted of two designs. There were retrospective design 
for hospitalized patient data for 2 years which all  population were taken as a sample; and cross-
sectional design for outpatient care data using purposive sampling methods to collect the sample 
for 3 months. Drug interactions were recorded and evaluated using DIPS (Drug Interaction 
Probability Scale) to determine the causation of interaction. Patients involved in this study were 
60 hospitalized patients and 22 outpatients. The total numbers of drug interactions occured in 
this study were 6 actual cases and 39 potential cases. Those include 60% in hospitalized patients 
and 13.6% in outpatient. The outcomes from this observation showed  that the interaction 
occurred mostly caused by asthma medication although it’s not harmful. Pharmacist’s role is 
needed in monitoring the medication to minimize and prevent adverse drug interactions. 
Polypharmacy and drug interaction represent potential health hazards for the patient. 
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Introduction  
 The National Asthma Education and Prevention Program (NAEPP) defines 
asthma as a chronic inflammatory disorder of the airways in which many cells and 
cellular elements play a role. In individuals with asthma, inflammation causes recurrent 
episodes of wheezing, shortness, chest thightness, and cough.
1
 Actual asthma symptoms 
can be treated and controlled, so that most patients can prevent the onset of symptoms 
throughout the day, to prevent a serious attack.
2
 It’s currently estimate that there are 
moret than 200 drugs known to affect the lungs adversely.
3
 It’s genereally 
acknowledges that patients with known asthma or chronic obstructive pulmonary 
disease are at the most significant risk tor drug-induced bronchospasm.
4
  Each patient 
should be assessed to find the right treatment regimen, adherence to treatment, and the 
